4/1
08:00 am
avdl
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
Medium
Report
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
3/25
08:08 am
avdl
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians [Yahoo! Finance]
Low
Report
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians [Yahoo! Finance]
3/25
08:00 am
avdl
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians
Low
Report
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians
3/5
08:00 am
avdl
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Low
Report
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
3/4
08:03 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
3/4
06:07 am
avdl
Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
Medium
Report
Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
3/3
08:44 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Medium
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
3/3
07:42 am
avdl
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/3
07:00 am
avdl
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
2/24
04:05 pm
avdl
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
Low
Report
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
2/24
09:04 am
avdl
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales [Yahoo! Finance]
Low
Report
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales [Yahoo! Finance]
2/24
08:00 am
avdl
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
Low
Report
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
2/20
04:05 pm
avdl
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2/11
07:26 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $12.00 price target on the stock.
2/10
09:54 am
avdl
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors [Yahoo! Finance]
Medium
Report
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors [Yahoo! Finance]
2/10
09:00 am
avdl
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
High
Report
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
1/22
08:00 am
avdl
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
Low
Report
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
1/13
02:56 pm
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at UBS Group AG from $22.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at UBS Group AG from $22.00 to $14.00. They now have a "buy" rating on the stock.
1/10
12:47 pm
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at Piper Sandler from $24.00 to $13.00. They now have an "overweight" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at Piper Sandler from $24.00 to $13.00. They now have an "overweight" rating on the stock.
1/10
08:03 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock, down previously from $25.00.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock, down previously from $25.00.
1/9
08:25 am
avdl
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at Needham & Company LLC from $22.00 to $19.00. They now have a "buy" rating on the stock.
Low
Report
Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at Needham & Company LLC from $22.00 to $19.00. They now have a "buy" rating on the stock.
1/8
04:15 pm
avdl
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
High
Report
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
1/6
04:05 pm
avdl
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)